BIDU coming off the bottom of a long term Broadening Formation, at a key level that has previously acted as strong demand zone. Could see a nice run back through previous range within the BF. Decent Risk Reward opportunity, options play. #TheStrat @RobInTheBlack @chuckthetrader
Covaxin Covid Vaccine approval decision expected Oct 5th. High and tight on the monthly. Over $7.12 triggers rev strat month. Used to be somebody! #TheStrat
